A comprehensive strategy that combines pharmacological advances, vector control, public outreach to raise awareness and ...
CHMP Adopts Positive Opinion for Aflibercept, Pegfilgrastim Biosimilars: On January 30, 2025, the European Medicines Agency (EMA) Committee ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results